Project 2VIDA! SARS-CoV-2 Vaccine Intervention Delivery for Adults in Southern California

项目总结 新冠肺炎对边缘化人群的影响不成比例，特别是黑人 和拉丁裔社区。在大流行之前，黑人和拉丁裔人口已经有了更高的 高血压、肺部疾病、心脏病和糖尿病等慢性病的比率， 这使得他们面临着更高的风险，与其他国家相比 非西班牙裔白人人口。虽然新冠肺炎疫苗接种已被确定为一种 应对新冠肺炎传播和严重程度的重要公共卫生措施，疫苗 犹豫不决仍然是一个重大问题。此前的研究表明，新冠肺炎疫苗与 黑人和拉丁裔社区对历史和当代的经验犹豫不决 医学种族主义；然而，黑人和拉丁裔中慢性病的高流行率 社区使围绕信任和疫苗犹豫不决的问题复杂化。例如，虽然 一些研究发现，患有慢性病的人对接受 新冠肺炎疫苗接种比个人没有慢性病，其他工作建议 被种族主义的慢性病患者仍然对疫苗犹豫不决。以前的研究 关于流感疫苗接种的研究还发现，疫苗接种迟疑不决与之前 慢性疾病患者的医疗虐待经历。的确有 一些证据表明，患有慢性病的种族主义个人不太可能 由于医疗种族主义的经历增加了不信任，寻求医疗护理，这 可能是导致疫苗犹豫不决的一个因素。虽然大量的研究已经 调查了种族主义人群和慢性病患者对疫苗的态度， 检验这些疾病的实际新冠肺炎疫苗结果的研究较少 人口。此外，已经有大量的研究呼吁使用方法 这可以通过以社区为基础的方式增加边缘化社区对疫苗接种的信任 由受信任的实体建立伙伴关系并提供疫苗信息。项目2VIDA！使用 社区参与的疫苗推广方法，并提供了宝贵的机会 检查患有慢性病的种族主义个人的疫苗结果。建议数 该项目将寻求更好地了解慢性身体健康之间的关系 2VIDA之间的条件、机构信任和疫苗结果！参与者使用 以社区为基础、混合方法的方法。这一分析将为以下方面提供更多背景 参与者的疫苗接种率和态度，以及扩大CBPR方法以 探索应用项目2VIDA成果的可能性！为未来的社区主导 干预措施。该项目还将允许培训一名来自 有弱势背景，致力于解决健康差距以及 通过导师和学术服务促进研究的多样性和包容性。

PROJECT SUMMARY COVID-19 has disproportionately impacted marginalized people, particularly those from Black and Latinx communities. Prior to the pandemic, Black and Latinx populations already had higher rates of chronic conditions such as hypertension, lung disease, heart disease, and diabetes, which have placed them at much higher risk for negative COVID-19 outcomes compared to non-Hispanic white populations. While COVID-19 vaccination has been identified as an important public health measure for addressing the spread and severity of COVID-19, vaccine hesitancy remains a significant issue. Previous research has linked COVID-19 vaccine hesitancy among Black and Latinx communities to historical and contemporary experiences of medical racism; however, the high prevalence of chronic conditions among Black and Latinx communities complicates questions around trust and vaccine hesitancy. For instance, while some research has found that individuals with chronic conditions were less hesitant to accept COVID-19 vaccination than individuals without chronic conditions, other work has suggested that racialized individuals with chronic conditions remained vaccine hesitant. Previous research on flu vaccination has also found an association between vaccine hesitancy and previous experiences of medical mistreatment among individuals with chronic health conditions. There is some evidence to suggest that racialized individuals with chronic conditions are less likely to seek medical care due to experiences of medical racism which have increased distrust, which may be one factor contributing to vaccine hesitancy. While a large body of research has examined vaccine attitudes among racialized populations and people with chronic conditions, there has been less research examining actual COVID-19 vaccine outcomes for these populations. Additionally, there has been a substantial amount of research calling for methods that can increase marginalized communities’ trust in vaccination through community-based partnerships and delivery of vaccine information by trusted entities. Project 2VIDA! uses a community-engaged approach to vaccine promotion and provides a valuable opportunity to examine vaccine outcomes for racialized individuals with chronic conditions. The proposed project will seek to better understand the relationship between chronic physical health conditions, institutional trust, and vaccine outcomes among 2VIDA! participants using community-based, mixed-methods approaches. This analysis will provide additional context for vaccine uptake and attitudes among participants as well as expanding the CBPR approach to explore possibilities for applying findings from Project 2VIDA! to future community-led interventions. This project will also allow the training of a junior researcher who comes from a disadvantaged background and is committed to addressing health disparities as well as advancing diversity and inclusion in research through mentorship and academic service.